Free Trial

Vigil Neuroscience (VIGL) Stock Price, News & Analysis

Vigil Neuroscience logo
$8.06 -0.01 (-0.12%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$8.06 +0.00 (+0.06%)
As of 07/15/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Vigil Neuroscience Stock (NASDAQ:VIGL)

Key Stats

Today's Range
$8.06
$8.09
50-Day Range
$2.31
$8.07
52-Week Range
$1.31
$8.09
Volume
383,843 shs
Average Volume
686,193 shs
Market Capitalization
$384.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.80
Consensus Rating
Hold

Company Overview

Vigil Neuroscience Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

VIGL MarketRank™: 

Vigil Neuroscience scored higher than 74% of companies evaluated by MarketBeat, and ranked 268th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Vigil Neuroscience has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 10 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Vigil Neuroscience has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Vigil Neuroscience's stock forecast and price target.
  • Earnings Growth

    Earnings for Vigil Neuroscience are expected to grow in the coming year, from ($2.07) to ($2.03) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Vigil Neuroscience is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Vigil Neuroscience is -3.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Vigil Neuroscience has a P/B Ratio of 4.61. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Vigil Neuroscience's valuation and earnings.
  • Percentage of Shares Shorted

    0.28% of the float of Vigil Neuroscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Vigil Neuroscience has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vigil Neuroscience has recently decreased by 65.75%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Vigil Neuroscience does not currently pay a dividend.

  • Dividend Growth

    Vigil Neuroscience does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.28% of the float of Vigil Neuroscience has been sold short.
  • Short Interest Ratio / Days to Cover

    Vigil Neuroscience has a short interest ratio ("days to cover") of 0.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Vigil Neuroscience has recently decreased by 65.75%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Vigil Neuroscience has a news sentiment score of 0.96. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Vigil Neuroscience this week, compared to 3 articles on an average week.
  • Search Interest

    6 people have searched for VIGL on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Vigil Neuroscience insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    18.01% of the stock of Vigil Neuroscience is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    83.64% of the stock of Vigil Neuroscience is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Vigil Neuroscience's insider trading history.
Receive VIGL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vigil Neuroscience and its competitors with MarketBeat's FREE daily newsletter.

VIGL Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
See More Headlines

VIGL Stock Analysis - Frequently Asked Questions

Vigil Neuroscience's stock was trading at $1.70 at the start of the year. Since then, VIGL stock has increased by 374.1% and is now trading at $8.06.

Vigil Neuroscience, Inc. (NASDAQ:VIGL) announced its quarterly earnings data on Wednesday, May, 7th. The company reported ($0.49) EPS for the quarter, beating analysts' consensus estimates of ($0.53) by $0.04.

Vigil Neuroscience (VIGL) raised $112 million in an initial public offering on Friday, January 7th 2022. The company issued 7,000,000 shares at $15.00-$17.00 per share.

Shares of VIGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vigil Neuroscience investors own include NVIDIA (NVDA), Meta Platforms (META), Exxon Mobil (XOM), JPMorgan Chase & Co. (JPM), Netflix (NFLX), Tesla (TSLA) and Home Depot (HD).

Company Calendar

Last Earnings
5/07/2025
Today
7/15/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VIGL
CIK
1827087
Fax
N/A
Employees
40
Year Founded
N/A

Price Target and Rating

High Price Target
$22.00
Low Price Target
$8.00
Potential Upside/Downside
+34.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.05)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$84.26 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-111.70%
Return on Assets
-74.67%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.97
Quick Ratio
2.97

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.75 per share
Price / Book
4.61

Miscellaneous

Outstanding Shares
47,687,000
Free Float
39,099,000
Market Cap
$384.36 million
Optionable
Not Optionable
Beta
3.34
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:VIGL) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners